Litcius/Paper detail

Genetic Inhibition of<i>PCSK9</i>and Liver Function

Antoine Rimbert, Sarra Smati, Wieneke Dijk, Cédric Le May, Bertrand Cariou

2020JAMA Cardiology32 citationsDOIOpen Access PDF

Abstract

This study investigates associations of the lifelong genetic inhibition of PCSK9 with plasma liver enzymes and nonalcoholic fatty liver disease by using the loss-of-function variant PCSK9-p.Arg46Leu as a genetic instrument.

Topics & Concepts

PCSK9MedicineNonalcoholic fatty liver diseaseLiver enzymeFatty liverLiver functionInternal medicineBioinformaticsDiseaseCholesterolLDL receptorBiologyLipoproteinLipoproteins and Cardiovascular HealthComputational Drug Discovery MethodsProtein Kinase Regulation and GTPase Signaling